In vivo permeability of the human blood-cerbrospinal fluid barrier in dementia
痴呆症中人血脑脊液屏障的体内通透性
基本信息
- 批准号:8768333
- 负责人:
- 金额:$ 23.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAttentionBiological MarkersBloodBlood VesselsBlood capillariesBrainCerebrospinal FluidCerebrumCognitionDataDementiaDetectionDevelopmentDiagnosisDiseaseDrug KineticsElderlyEpithelialEpithelial CellsEpitheliumEquilibriumExtravasationFunctional disorderGoalsHealthHomeostasisHumanImpaired cognitionIntercellular FluidIntercellular JunctionsIntraventricularInvestigationKnowledgeLaboratoriesLifeLiquid substanceMagnetic Resonance ImagingMeasurementMeasuresMemoryMetabolismMicrovascular PermeabilityModelingMolecularNeurofibrillary TanglesNeuropsychological TestsNoisePathogenesisPatientsPeptidesPermeabilityProcessProductionProtonsReagentRelaxationRoleSideSignal TransductionSpeedStructureStructure of choroid plexusSurfaceSymptomsTestingTissue ModelTissuesVenousVentricularWaterWorkabeta accumulationaging brainbaseblood cerebrospinal fluid barriercapillarycognitive changecognitive functioncognitive testingcontrast enhanceddesignexecutive functionimaging biomarkerimprovedin vivoinsightmacromoleculemagnetic fieldneuroimagingneuropsychologicalneurotransmissionnovel therapeutic interventionperipheral bloodpharmacokinetic modelsoluteventricular system
项目摘要
DESCRIPTION (provided by applicant): The choroid plexus (CP) forms an interface between the blood and cerebrospinal fluid (CSF) and works in concert with brain capillaries to assure fluid homeostasis throughout the brain. Bounded on one side by ventricular CSF and on the other by a dense, highly permeable vascular network, the CP contains the blood- CSF barrier, a single layer of epithelial cells that secrete the majority of CSF in the brain and, by virtue of tiht intercellular junctions, regulates the exchange of macromolecules between the blood and CSF. Once across the barrier, solutes are transported to the surface of the brain where they are absorbed into the venous blood or mix with interstitial fluid and are carried deep into the parenchyma. Alzheimer's disease (AD) is the most commonly diagnosed form of dementia in the elderly and the accumulation of amyloid-ß peptides the histopathological hallmark of the disease. Amyloid-ß levels in the CP increase in AD and could alter the permeability of the CP. We hypothesize that permeability disturbances could have large effects on CSF hydrodynamics and increase concentrations of amyloid-ß throughout the brain. The proposed project will use ultra-high field dynamic contrast enhanced magnetic resonance imaging and a compartmental tissue model that explicitly accounts for intercompartmental water exchange to quantify CP permeability in vivo and determine the extent to which it is associated with cognitive function in early AD. We expect that the accurate, non-invasive measurement of CP permeability, together with cognitive assessments, will provide critical insight into the role of the blood-CSF barrier in
the cognitive decline that characterizes AD. Such information will be important in understanding the pathophysiology of AD and the rational treatment of incipient disease.
描述(由适用提供):脉络丛(CP)在血液和脑脊液(CSF)之间形成界面,并与脑毛细血管协同合作,以确保整个大脑中的液体稳态。 CP由心室CSF和另一侧界定在另一侧,另一方面是由密集的,高度可渗透的血管网络限制的,其中包含血液CSF屏障,这是一个单层的上皮细胞,这些细胞向大脑中的大多数CSF秘密,并通过tiht tiht层间插条的优点调节了大粒细胞之间的血液中血细胞的交换,从而调节了大脑的交换。一旦穿过障碍物,便士就会将其吸收到静脉血液中或与间质液混合到大脑表面,并将其深入实质。阿尔茨海默氏病(AD)是古老的痴呆症最常见的形式,淀粉样蛋白 - β肽的积累是该疾病的组织病理学标志。 CP中AD的淀粉样蛋白水平增加,可能会改变CP的渗透性。我们假设渗透性障碍可能对CSF流体动力学产生很大的影响,并增加整个大脑中淀粉样蛋白 - β的浓度。拟议的项目将使用超高的场动态对比度增强磁共振成像和隔室组织模型,该模型明确说明了班级间的水交换,以量化体内的CP渗透率,并确定与早期AD中认知功能相关的程度。我们预计,CP渗透性的准确性,非侵入性测量以及认知评估将提供对血液-CSF屏障在
角色广告的认知下降。此类信息对于理解AD的病理生理学和初期疾病的合理治疗将很重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VALERIE C ANDERSON其他文献
VALERIE C ANDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VALERIE C ANDERSON', 18)}}的其他基金
In vivo permeability of the human blood-cerbrospinal fluid barrier in dementia
痴呆症中人血脑脊液屏障的体内通透性
- 批准号:
9134651 - 财政年份:2015
- 资助金额:
$ 23.04万 - 项目类别:
Quantitative Measurement of Cerebrovascular Permeability in Early Dementia
早期痴呆脑血管通透性的定量测量
- 批准号:
7787854 - 财政年份:2009
- 资助金额:
$ 23.04万 - 项目类别:
Quantitative Measurement of Cerebrovascular Permeability in Early Dementia
早期痴呆脑血管通透性的定量测量
- 批准号:
8134284 - 财政年份:2009
- 资助金额:
$ 23.04万 - 项目类别:
Quantitative Measurement of Cerebrovascular Permeability in Early Dementia
早期痴呆脑血管通透性的定量测量
- 批准号:
8306203 - 财政年份:2009
- 资助金额:
$ 23.04万 - 项目类别:
OPEN LABEL, DOSE ESCALATION STUDY OF SNX-111 ADMINISTERED INTRATHECALLY TO PT
SNX-111 鞘内给予 PT 的开放标签剂量递增研究
- 批准号:
6116983 - 财政年份:1998
- 资助金额:
$ 23.04万 - 项目类别:
OPEN LABEL, DOSE ESCALATION STUDY OF SNX-111 ADMINISTERED INTRATHECALLY TO PT
SNX-111 鞘内给予 PT 的开放标签剂量递增研究
- 批准号:
6278178 - 财政年份:1997
- 资助金额:
$ 23.04万 - 项目类别:
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 23.04万 - 项目类别:
Ultra-precision clinical imaging and detection of Alzheimers Disease using deep learning
使用深度学习进行超精密临床成像和阿尔茨海默病检测
- 批准号:
10643456 - 财政年份:2023
- 资助金额:
$ 23.04万 - 项目类别:
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
- 批准号:
10661931 - 财政年份:2023
- 资助金额:
$ 23.04万 - 项目类别:
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
前驱期和症状性路易体病中的微生物组-肠-脑功能障碍
- 批准号:
10720677 - 财政年份:2023
- 资助金额:
$ 23.04万 - 项目类别:
Midlife cardiovascular stress physiology and preclinical cerebrovascular disease
中年心血管应激生理学与临床前脑血管疾病
- 批准号:
10720054 - 财政年份:2023
- 资助金额:
$ 23.04万 - 项目类别: